Skip to main content

Advertisement

Log in

The state of cartilage regeneration: current and future technologies

  • Biological Adjuvants in Orthopedic Surgery (J Dines and D Grande, Section Editors)
  • Published:
Current Reviews in Musculoskeletal Medicine Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

It is clear that mature human articular cartilage does not have the innate ability to regenerate. Due to this, much effort has been put forth to work on bestowing this ability. While early data focused on more basic outcomes such as percentage of defect fill, the tissue formed was a “cartilage scar” or “hyaline-like” tissue. Even with more advanced technologies, it is clear that no current procedure is able to reconstitute the native structure and function of true hyaline cartilage. As research advancement has somewhat plateaued in this regard, it is crucial that future work focuses on a multifactorial approach, treating the joint as an organ system. The purpose of this review is to update readers on the most recent literature and controversies surrounding articular cartilage regeneration. Specific focus will be placed on current technologies available in the USA and the basic science to support them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Papadopoulou AK, Papachristou DJ, Chatzopoulos SA, Pirttiniemi P, Papavassiliou AG, Basdra EK. Load application induces changes in the expression levels of Sox-9, FGFR-3 and VEGF in condylar chondrocytes. FEBS Lett. 2007;581:2041–6.

    Article  CAS  PubMed  Google Scholar 

  2. Salter RB, Field P. The effects of continuous compression on living articular cartilage an experimental investigation. J Bone Joint Surg Am. 1960;42:31–90.

    Google Scholar 

  3. Freyria A-M, Mallein-Gerin F. Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors. Injury. 2012;43(3):259–65.

  4. Frisbie DD, Morisset S, Ho CP, Rodkey W, Steadman RJ, McIlwraith CW. Effects of calcified cartilage on healing of chondral defects treated with microfracture in horses. Am J Sports Med. 2006;34:1824–31.

    Article  PubMed  Google Scholar 

  5. Goyal D, Keyhani S, Lee EH, Hui JHP. Evidence-based status of microfracture technique: a systematic review of level I and II studies. Arthroscopy. 2013;29:1579–88.

    Article  PubMed  Google Scholar 

  6. Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med. 2009;37:2053–63. This is a key article for understanding which patients will benefit from microfracture.

    Article  PubMed  Google Scholar 

  7. Kreuz P, Steinwachs M, Erggelet C, KRAUSE S, KONRAD G, UHL M, et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee1. Osteoarthritis Cartilage. 2006;14:1119–25.

    Article  CAS  PubMed  Google Scholar 

  8. Negrin L, Kutscha-Lissberg F, Gartlehner G, Vécsei V. Clinical outcome after microfracture of the knee: a meta-analysis of before/after-data of controlled studies. Int Orthop. 2012;36:43–50.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Gudas R, Kalesinskas RJ, Kimtys V, Stankevicius E, Toliusis V, Bernotavicius G, et al. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy. 2005;21:1066–75.

    Article  PubMed  Google Scholar 

  10. Minas T, Gomoll AH, Rosenberger R, Royce RO, Bryant T. Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques. Am J Sports Med. 2009;37:902–8. This is currently a controversial topic, but spurs the question as to whether performing microfracture may burn a bridge to future treatment.

    Article  PubMed  Google Scholar 

  11. Pestka JM, Niemeyer P, Bode G, Salzmann G, Südkamp NP. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint. Am J Sports Med. 2012;40:325–31.

    Article  PubMed  Google Scholar 

  12. McNickle AG, Cole BJ, L’Heureux DR, Yanke AB. Outcomes of autologous chondrocyte implantation in a diverse patient population. Am J Sports Med. 2009;37:1344–50.

    Article  PubMed  Google Scholar 

  13. Chen H, Buschmann MD, Hoemann CD, Sun J, Chevrier A, McKee MD, et al. Depth of subchondral perforation influences the outcome of bone marrow stimulation cartilage repair. J Orthop Res. 2011;29:1178–84.

    Article  PubMed  Google Scholar 

  14. Franssen B, van Diest PJ, Schuurman AH, Kon M. Keeping osteocytes alive: a comparison of drilling and hammering K-wires into bone. J Hand Surg Eur Vol. 2008;33(3):363–8.

  15. Stanish WD, McCormack R, Forriol F, Mohtadi N, Pelet S, Desnoyers J, et al. Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. J Bone Joint Surg Am. 2013;95:1640–50.

    Article  PubMed  Google Scholar 

  16. McCormick F, Cole BJ, Yanke AB, Provencher MT. Minced articular cartilage—basic science, surgical technique, and clinical application. Sports Med Arthrosc. 2008;16:217–20.

    Article  PubMed  Google Scholar 

  17. Adkisson HD, Martin JA, Amendola RL, Milliman C, Mauch KA, Katwal AB, et al. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage. Am J Sports Med. 2010;38:1324–33.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Bonasia DE, Martin JA, Marmotti A, Amendola RL, Buckwalter JA, Rossi R, et al. Cocultures of adult and juvenile chondrocytes compared with adult and juvenile chondral fragments: in vitro matrix production. Am J Sports Med. 2011;39:2355–61.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Tompkins M, Hamann JC, Diduch DR, Bonner KF, Hart JM, Gwathmey FW, et al. Preliminary results of a novel single-stage cartilage restoration technique: particulated juvenile articular cartilage allograft for chondral defects of the patella. Arthroscopy. 2013;29:1661–70.

    Article  PubMed  Google Scholar 

  20. Farr J, Tabet SK, Margerrison E, Cole BJ. Clinical, radiographic, and histological outcomes after cartilage repair with particulated juvenile articular cartilage: a 2-year prospective study. Am J Sports Med. 2014;0363546514528671. Dr. Farr has been pioneer in using minced juvenile cartilage, and his group will continue to put out what is likely the most current data on this topic.

  21. Chubinskaya S, Wepking K, Hakimiyan A, Margulis A, Rappoport L, Cole BJ. In vitro evaluation of minced adult and juvenile articular cartilage: a time course analysis. Izmir: International Cartilage Repair Society; 2013.

    Google Scholar 

  22. Lu Y, Cole BJ, Dhanaraj S, Wang Z, Bradley DM, Bowman SM, et al. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res. 2006;24:1261–70.

    Article  PubMed  Google Scholar 

  23. Frisbie DD, Lu Y, Kawcak CE, DiCarlo EF, Binette F, McIlwraith CW. In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation. Am J Sports Med. 2009;37 Suppl 1:71S–80.

    Article  PubMed  Google Scholar 

  24. Cole BJ, Farr J, Winalski CS, Hosea T, Richmond J, Mandelbaum B, et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med. 2011;39:1170–9.

    Article  PubMed  Google Scholar 

  25. Kreuz PC, Steinwachs M, Erggelet C, Krause SJ, Ossendorf C, Maier D, et al. Classification of graft hypertrophy after autologous chondrocyte implantation of full-thickness chondral defects in the knee. Osteoarthr Cartil. 2007;15:1339–47.

    Article  CAS  PubMed  Google Scholar 

  26. Moradi B, Schönit E, Nierhoff C, Hagmann S, Oberle D, Gotterbarm T, et al. First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years’ clinical and magnetic resonance imaging follow-up evaluation. Arthroscopy. 2012;28:1851–61.

    Article  PubMed  Google Scholar 

  27. Minas T, Keudell Von A, Bryant T, Gomoll AH. The John Insall award: a minimum 10-year outcome study of autologous chondrocyte implantation. Clin Orthop Relat Res. 2013. This is a great paper to reinforce that for large, shallow defects, ACI is the technology to beat, not microfracture.

  28. Vijayan S, Bartlett W, Bentley G, Carrington RWJ, Skinner JA, Pollock RC, et al. Autologous chondrocyte implantation for osteochondral lesions in the knee using a bilayer collagen membrane and bone graft: a two- to eight-year follow-up study. J Bone Joint Surg Br. 2012;94:488–92.

    Article  CAS  PubMed  Google Scholar 

  29. Chubinskaya S, Cole BJ, Hakimiyan AA, Rappoport L, Yanke AB, Rueger DC. Response of human chondrocytes prepared for autologous implantation to growth factors. J Knee Surg. 2008;21:192–9.

    Article  PubMed  Google Scholar 

  30. Van Assche D, Staes F, Van Caspel D, Vanlauwe J, Bellemans J, Saris DB, et al. Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc. 2010;18:486–95.

    Article  PubMed  Google Scholar 

  31. Knutsen G, Drogset JO, Engebretsen L, Grøntvedt T, Isaksen V, Ludvigsen TC, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89:2105–12.

    Article  PubMed  Google Scholar 

  32. Lee KBL, Hui JHP, Song IC, Ardany L, Lee EH. Injectable mesenchymal stem cell therapy for large cartilage defects–a porcine model. Stem Cells. 2007;25:2964–71.

    Article  PubMed  Google Scholar 

  33. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:223.

    Article  PubMed Central  PubMed  Google Scholar 

  34. Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007;25:230–40.

    Article  CAS  PubMed  Google Scholar 

  35. McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27:1033–42.

    Article  CAS  PubMed  Google Scholar 

  36. Fortier LA, Potter HG, Rickey EJ, Schnabel LV, Foo LF, Chong LR, et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am. 2010;92:1927–37. This is one of the most well performed microfracture augmentation sutdies done in an equine model. Adding beneficial growth factors to current cartilage technology will likely be a common occurrence in the future.

    Article  PubMed  Google Scholar 

  37. Liu Y, Shu XZ, Prestwich GD. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng. 2006;12:3405–16.

    Article  CAS  PubMed  Google Scholar 

  38. Gigante A, Cecconi S, Calcagno S, Busilacchi A, Enea D. Arthroscopic knee cartilage repair with covered microfracture and bone marrow concentrate. Arthroscop Tech. 2012;1:e175–80.

    Article  Google Scholar 

  39. Nejadnik H, Hui JH, Feng Choong EP, Tai B-C, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38:1110–6. This work along with the work that uses adipose derived stem cells, suggests that single stage arthroscopic procedures may be possible in the future along with being less age dependent.

    Article  PubMed  Google Scholar 

  40. Yang S-E, Ha CW, Jung M, Jin H-J, Lee M, Song H, et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004;6:476–86.

    Article  PubMed  Google Scholar 

  41. Kim J-Y. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. WJSC. 2010;2:34.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Hunter DJ, Pike MC, Jonas BL, Kissin E, Krop J, McAlindon T. Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2010;11:232.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Lohmander LS, Hellot S, Dreher D, Krantz EFW, Kruger DS, Guermazi A, et al. Intra-articular Sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;n/a–n/a.

  44. Moore EE, Bendele AM, Thompson DL, Littau A, Waggie KS, Reardon B, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthr Cartil. 2005;13:623–31.

    Article  CAS  PubMed  Google Scholar 

  45. Leitner GC, Gruber R, Neumüller J, Wagner A, Kloimstein P, Höcker P, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang. 2006;91:135–9.

    Article  CAS  PubMed  Google Scholar 

  46. Cole BJ, Boswell SG, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39. Studies such as this are important as new products arrive (PRP, ACS, etc.) as the combination of factors injected is important to understand. This also varies significantly based on the manufacturer and process utilized.

    Article  PubMed  Google Scholar 

  47. Yin Z, Yang X, Jiang Y, Xing L, Xu Y, Lu Y, et al. Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study. J Biomater Appl. 2014;28:1039–50.

    Article  CAS  PubMed  Google Scholar 

  48. Dold AP, Zywiel MG, Taylor DW, Dwyer T, Theodoropoulos J. Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin J Sport Med. 2014;24:31–43.

    Article  PubMed  Google Scholar 

  49. Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40:534–41.

    Article  PubMed  Google Scholar 

  50. Wehling P, Moser C, Frisbie D, McIlwraith CW, Kawcak CE, Krauspe R, et al. Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs. 2007;21:323–32.

    Article  CAS  PubMed  Google Scholar 

  51. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 2007;68:290–6.

    Article  PubMed  Google Scholar 

  52. Baltzer AWA, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthr Cartil. 2009;17:152–60. This is arguably the highest profile article that has been published on Orthokine. Keep an eye out for further publication on its contents and efficacy that are not sponsored by the supplier to minimize bias.

    Article  CAS  PubMed  Google Scholar 

  53. Rutgers M, Saris DBF, Dhert WJA, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Arthritis Res Ther. 2010;12:R114.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Adam B. Yanke receives research support from Arthrex and NuTech companies.

Susan Chubinskaya reports grants from Rush University Ciba-Geigy Endowed Chair, grants from Joint restoration foundation, grants from Zimmer during the conduct of the study, grants from Cartiheal, and grants from Merrimackpharma, outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adam B. Yanke.

Additional information

This article is part of the Topical Collection on Biological Adjuvants in Orthopedic Surgery

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanke, A.B., Chubinskaya, S. The state of cartilage regeneration: current and future technologies. Curr Rev Musculoskelet Med 8, 1–8 (2015). https://doi.org/10.1007/s12178-014-9254-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12178-014-9254-7

Keywords

Navigation